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The objective of this article was to compare the costs and cost-effectiveness of the two
most prominent types of case management in the Netherlands (intensive case manage-
ment and linkage models) against no access to case management (control group) for peo-
ple with already diagnosed dementia and their informal caregivers.
Methods
The economic evaluation was conducted from a societal perspective embedded within a
two year prospective, observational, controlled, cohort study with 521 informal caregivers
and community-dwelling persons with dementia. Case management provided within one
care organization (intensive case management model, ICMM), case management where
care was provided by different care organizations within one region (Linkage model, LM),
and a group with no access to case management (control) were compared. The economic
evaluation related incremental costs to incremental effects regarding neuropsychiatric
symptoms (NPI), psychological health of the informal caregiver (GHQ-12), and quality
adjusted life years (QALY) of the person with dementia and informal caregiver.
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Results
Inverse-propensity-score-weighted models showed no significant differences in clinical or
total cost outcomes between the three groups. Informal care costs were significantly lower
in the ICMM group compared to both other groups. Day center costs were significantly
lower in the ICMM group compared to the control group. For all outcomes, the probability
that the ICMM was cost-effective in comparison with LM and the control group was larger
than 0.97 at a threshold ratio of 0 €/incremental unit of effect.
Conclusion
This study provides preliminary evidence that the ICMM is cost-effective compared to the
control group and the LM. However, the findings should be interpreted with caution since
this study was not a randomized controlled trial.
Introduction
Dementia is a chronic disorder marked by memory loss, cognitive impairment and behavioral
lapses resulting in pronounced consequences for the people with dementia, their families and
society. The global prevalence of dementia is estimated at 48.1 million in 2020 and is expected
to rise to approximately 90.3 million in 2040 [1]. Worldwide costs of dementia were estimated
at US$ 604 billion in 2010 [2, 3]. In high-income countries, informal care (45%) and formal
social care (40%) make up the majority of costs, while the contribution of direct medical costs
(15%) is smaller [2, 3]. The expected increase in the number of people with dementia will lead
to increased long-term care needs, while meeting these needs will become more difficult in the
future due to the decreasing workforce. Therefore, the provision and financing of care options
for people with dementia and their informal caregivers is an important societal and political
issue [1].
Although there is a variety of community and care services available for community-dwell-
ing people with dementia and their informal caregivers, people often lack information regard-
ing available support that may address their care needs [4, 5]. Many experience insufficient
alignment, management and continuity of care and support during the disease course [6].
Around 80 percent of caregivers are at risk of becoming overburdened, and this is one of the
major risk factors for acute hospitalisation and institutionalization of persons with dementia
[7, 8]. Moreover, informal caregivers of persons with dementia are at high risk of developing
depressive or anxiety disorders [9, 10].
Case management has been proposed as an instrument to delay institutionalization of the
person with dementia and improve the mental health of informal caregivers. Case management
is defined as a “collaborative process of assessment, planning, facilitation, care coordination,
evaluation, and advocacy for options and services to meet an individual’s and family’s compre-
hensive health needs through communication and available resources to promote quality and
cost-effective outcomes”[11]. Reviews and meta-analyses have yielded inconsistent results
regarding case management on person with dementia and caregivers outcomes such as care
satisfaction, institutionalization, hospitalization, caregiver burden and depression, and eco-
nomic outcomes [12–15].
The objective of this article was to compare the costs and cost-effectiveness of the two most
prominent types of case management in the Netherlands (intensive case management and link-
age models) against no access to case management (control group) for people with already
diagnosed dementia and their informal caregivers.
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Methods
The COMPAS (Case management of persons with dementia and their caregivers) project was a
prospective, observational, controlled, cohort study. The study protocol was registered with the
Dutch Trials Registry (NTR3268) and published elsewhere [16, 17]. This study was a non-ran-
domized control prospective observational study where the intervention was already imple-
mented in the community prior to the start of this study making the registration of this study
with the NTR a voluntary action after we started recruitment. The authors confirm that all
ongoing and related trials for this intervention are registered. The Medical Ethics Committee
of the VU University medical center approved this study in November 2010 and all partici-
pants gave written consent. The informal caregiver signed on behalf of the person with demen-
tia if they were unable to understand and reproduce the study goals.
Participants and setting
The primary informal caregivers (n = 521) and persons with dementia were recruited from var-
ious regions of the Netherlands from April 2011 to November 2012. The last follow-up inter-
view was done at the end of June 2014. Recruitment areas included rural areas in the north of
Netherlands, semi-rural areas outside of Amsterdam, and urban areas such as Amsterdam. In
case management regions, case managers of the participating organizations provided lists of
their clients who already receiving care and met the inclusion criteria. In the control group,
recruitment took place via outpatient geriatric or neurologic (memory) clinics, Alzheimer cen-
ters and general medical practices. Persons with dementia were eligible for this study if they
lived at home, had an established/formal diagnosis of dementia, were not terminally-ill, were
not anticipated to be admitted to a long term care facility within 6 months, and had an infor-
mal caregiver. The informal caregivers were eligible if they were the primary informal caregiver
responsible for caring for the person with dementia, had sufficient language proficiency and
were not severely ill.
Care models
The case management models that were evaluated in this study and the content of care in
regions without case management were described in detail elsewhere and summarized here
[16, 18]. Also, in an additional table the models are compared with each other (S2 Table).
Case managers in the Intensive Case Management Model (ICMM) are appointed at one
organization which is specialized in dementia care. They guide and support people with
dementia for long periods of time usually starting after diagnosis, and offer medical and psy-
chosocial services from within their own organization [19]. The case manager works in collabo-
ration with an ‘in-home’ multidisciplinary team to tailor care needs of the person with
dementia and the informal caregiver [19].
The Linkage Model (LM) is a collaboration between multiple care providers (e.g. home care
organizations, general practitioners, social care services) who were already providing health
care services in the region and were given the mandate to initiate case management services.
After a formal diagnosis, persons with dementia are assigned to a case manager who provides
educational, emotional and practical support such as advice on disease-related issues, and gives
recommendations on the availability of supportive health and social services until time of nurs-
ing home admission or death of the persons with dementia. In general, informal caregivers are
involved in this process whenever possible. Expert advice can be sought through multidisci-
plinary meetings held regularly with experts from the various collaborating organizations.
The control group was recruited in areas without access to a case manager [20]. In these
regions, no central coordination of dementia care is provided by a dedicated, trained and
Economic Evaluation of Case Management Models in Dementia Care
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educated health care professional. Care is usually initiated by the person with dementia,
his /her informal caregiver or an involved health care provider. In some cases, care may be
monitored by a registered nurse working in the general practice in addition to the general prac-
titioner. Access to home or respite care did not differ across regions.
Data collection
Data were collected through interviews and questionnaires administered by trained interview-
ers at baseline and every six months for 24 months. The informal caregiver filled in cost diaries
that were collected at each interview.
Outcome measures
The primary outcome in the person with dementia was the presence of neuropsychiatric symp-
toms as measured with the Neuropsychiatric Inventory (NPI) which assesses twelve neuropsy-
chiatric domains in persons with dementia [21]. The NPI was rated by a caregiver familiar with
the person with dementia’s behaviour [21]. Presence, frequency, severity and the symptom spe-
cific caregiver distress in the previous month are assessed [21]. Calculation of the total score
was the sum of the 12 domain scores which ranges from 0–144 points with higher scores indi-
cating more problems [21].
The primary outcome in the informal caregiver was psychological or mental health as mea-
sured by the general health questionnaire (GHQ-12) [22]. The score ranges from 0–12 with
higher scores indicating more severe psychological health problems.
Secondary outcomes included Quality-Adjusted Life-Years (QALYs) based on the EuroQol
(EQ-5D-3L)[23]. EQ-5D-3L data for the person with dementia were collected by interviewing
the informal caregiver [24]. The questions were specifically framed so the informal caregiver
would answer taking in mind how their loved one would answer each question and not their
personal opinion. Informal caregivers also filled out the EQ-5D-3L for themselves so that their
own health related quality of life could be evaluated. The EQ-5D-3L includes 5 dimensions:
mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The respondent
answers each of the EQ-5D-3L’s 5 dimensions with 1 of 3 possible responses: “no problems,”
“some problems,” or “severe problems.” The set of 5 responses defines a health state [23]. The
243 (35) possible health states are weighted using a valuation set from a sample of the Dutch
general population known as the Dutch EQ-5D-3L tariff resulting in a utility score [25]. This
utility reflects the relative desirability of a particular health state and is measured on a scale in
which 0 is anchored to death and 1 to perfect health. We calculated QALYs by multiplying the
utility of each health state by the time in between two measurements and summing the results
over the 24 month treatment period. QALYs were calculated using the area under the curve
approach. Transitions between health states were linearly interpolated.
Subsequently, combined QALY scores for the pairs were calculated by summing the QALYs
for the person with dementia and the caregiver. The rationale was that case management can
influence outcomes at the level of both the informal caregiver and the person with dementia,
which we tried to account for by calculating a combined QALY score.
Costs
Resource utilization and associated costs were measured from a societal perspective. Cost dia-
ries were used to collect data on use of care and support by persons with dementia and the
informal caregiver? to estimate costs from a societal perspective. Direct healthcare costs
included formal care such as general practitioner visits and medication use. Direct non-health-
care costs consisted of time spent on care by informal carers. We limited the maximum number
Economic Evaluation of Case Management Models in Dementia Care
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of informal care hours per day to 18 hours. Indirect non-healthcare costs included days absent
from paid work or unable to do daily activities such as housekeeping or voluntary work because
of caregiver responsibilities. S1 Table lists the cost categories and prices used in the economic
evaluation. All prices were adjusted for the year 2010 using consumer price index figures [26].
Healthcare utilization, and absenteeism from paid and unpaid work was valued using Dutch
standard costs [27]. Medication use was valued using prices from the Royal Dutch Society for
Pharmacy [28].
To estimate the costs of case management, 73 case managers (92% of all case managers that
were included in this study) were interviewed about their caseloads and the number of hours
they worked per week. Based on this information we calculated the time spent per client
including travel time, and valued this using the median hourly wage for a case manager.
Costs and effects in the second year were discounted at 4% and 1.5% respectively based on
Dutch guidelines for economic evaluations [29].
Statistical analysis
As this was a non-randomized controlled study, advanced statistical methods were needed to
control for any baseline imbalances between the different treatment groups [30]. Therefore,
propensity scores were calculated using generalized boosted methods for multiple treatments
using the ‘twang’ package in R [31]. Balance and overlap of propensity score distributions in
the three groups were assessed. The ‘twang’ package provides propensity scores based weights
for the estimation of the average treatment effects (ATE) for more than two treatment groups.
All covariates that significantly differed among groups at baseline or that were associated with
the baseline NPI total score were included in the calculation of propensity score and weights.
We checked the weighted averages of the covariates to confirm that there were no longer any
baseline differences between the groups. A separate propensity score and weight was created
for secondary outcomes that included variables that significantly differed at baseline. The pro-
pensity score based weights were then exported to Stata to be used as sampling weights in the
analysis [32].
Several studies showed that using complete case analysis is likely to result in bias in eco-
nomic evaluations [33–35]. Therefore, multiple imputation by chained equations (MICE)
using predictive mean matching (PMM) was used to impute missing values for cost and effect
data [33]. Variables associated with missingness in the current study included: education, living
situation, sex of the person with dementia, MMSE, care needs, mastery of the informal care-
giver, relationship to the person of dementia, loneliness of informal caregiver, age of the infor-
mal caregiver, baseline NPI, multimorbidity, Katz and the carerQol. Because we felt that we
could properly explain the missing data mechanism, we assumed that data was missing at ran-
dom (MAR) which is a prerequisite for using multiple imputation (MI). MI was done taking
into account recommendations presented in various recent papers [33, 34, 36].
We created 100 imputed datasets. We included the propensity weight as one of the predictor
variables in the imputation model [30]. The analysis results from the imputed datasets were
pooled together using Rubin’s rules [37]. Individual sub costs per category were imputed
instead of total costs to maximize the accuracy of the imputation.
We used a generalized linear regression model with a gamma distribution and an identity
link to estimate mean differences in total costs while accounting for the right skew of the cost
data. The incremental effect in quality adjusted life years (QALYs) was estimated using a using
a generalized linear regression model adjusted for baseline utility scores with a Gaussian distri-
bution and an identity link [38]. A generalized estimating equation (GEE) model was used to
estimate NPI and GHQ-12 scores to allow for repeated measurements. An exchangeable
Economic Evaluation of Case Management Models in Dementia Care
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correlation structure was used with robust standard errors. The estimated changes in mean
NPI, GHQ and sub costs that are reported are for the two year follow-up period.
We estimated the correlation between the incremental total costs and the different outcome
measures in the imputed datasets. In the multiple imputation procedure, the covariance
between total costs and effect outcomes measures were calculated based on the Fisher z trans-
formation and were then pooled using Rubin’s rules [36, 39].
Incremental Cost-Effectiveness Ratios (ICERs) were calculated using the pooled cost and
effect estimates. The ICER is calculated as D^c
D^e
where D^c is the difference in total costs between
the two intervention groups and D^e is the difference in QALYs between the two intervention
groups. To show uncertainty around the ICER a cost-effectiveness plane was estimated using
bootstrapping with 1000 replications using the syntax developed by Faria et al [34].
Incremental net benefit (INB) estimates were calculated using the following formula:
b^ðlÞ ¼ D^el D^c [40, 41] where D^e is the difference in outcome (for example QALY) between
the two intervention groups, λ is the willingness to pay, and D^c is the difference in costs. The
variance of INB was calculated using: V ½b^ðlÞ ¼ V^ ðD^eÞl2 þ V^ ðD^cÞ  2C^ðD^e; D^cÞl where C^ is
the covariance between the differences in total costs and QALYs [40, 41]. The probability of
cost-effectiveness was calculated by estimating the probability that INB was positive using a
normal-based approach. Using the pooled NMB and the pooled standard error of NMB, the
probability that NMB is larger than zero was estimated for a range of willingness-to-pay values.
These probabilities were then used to estimate cost-effectiveness acceptability curves (CEACs)
which is a plot of the probability that the intervention is cost-effective in comparison with its
comparator (y-axis) as a function of the money society might be willing to pay for one addi-
tional unit of outcome (threshold ratio (λ), x-axis). In this way, CEACs quantify the uncer-
tainty due to sampling and measurement errors while taking into account that λ is generally
unknown [40, 41]. The pooled coefﬁcients and variance parameters from the regression models
were used to estimate the CEACs. CEACs were estimated for three comparisons: ICMM versus
control, LM versus control, and ICMM versus LM. The Netherlands has a “rule of thumb”
value for λ of around 30,000 €/QALY [29]. Therefore, probabilities of cost-effectiveness for all
outcomes at this value for λ were presented as part of the cost-effectiveness outcomes.
Results
Fig 1 shows the flow of participants in the study. Of the 2,810 caregiver and person with
dementia pairs assessed for eligibility, 1,628 met all inclusion criteria and were sent recruitment
letters. Five hundred and twenty-one of these individuals agreed to participate (32%) and 1,107
(68%) refused to participate. We had information on the gender of the person with dementia,
the gender of the caregiver and the relationship of the informal caregiver to the person with
dementia for 1,172 (72%) people that were approached. The only difference we found was that
informal caregivers who were the partner of the person with dementia were more willing to
participate than those who had another type of relationship (χ2 = 11 df = 1, p<0.001).
Participant characteristics and differences between groups are shown in Table 1. Of the 521
participants included, 234 (45%) participated in the ICMM group, 73 (14%) in the control
group and 214 (41%) in the LM group. The average age of informal caregivers was 65 years
(range 22–91 years), and the average age of the person with dementia was 80 years (range 54–
97 years). Sixty-seven percent of the informal caregivers and 55% of the persons with dementia
were female. The number of participants that dropped out was 219 (42%) after 24 months. The
rate of drop out did not differ per group and the main reason for drop out was death of the per-
son with dementia (n = 82/219, 37%). There was no significant difference in the proportion of
Economic Evaluation of Case Management Models in Dementia Care
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deaths between the three groups (n = 39 deaths for ICMM n = 32 for LM and n = 11 for control
group). Persons with dementia who died during the study were more likely to be older (-3.1
Fig 1. Consort diagram.Recruitment overview.
doi:10.1371/journal.pone.0160908.g001
Economic Evaluation of Case Management Models in Dementia Care
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Table 1. Baseline table of characteristics of care models, persons with dementia and informal caregivers.
Intensive Case Management Linkage model Control Total group P- value
Person with Dementia N = 234 N = 214 N = 73 N = 521
Age, mean (SD) a 79.9 81.0 75.9 79.8 < 0.001
(7.7) (7.5) (8.7) (7.9)
Female gender, n (%) b 122 134 32 288 0.009
(52.4) (62.6) (43.8) (55.3)
Married or in a relationship, n (%) b 128 98 51 277 0.003
(56.4) (47.8) (70.8) (55.0)
Living situation 0.065
Living alone, n (%) b 92 95 19 206
(40.5) (46.3) (26.8) (41.0)
Living with another person 130 105 49 284
(57.3) (51.2) (69.0) (56.5)
Living in an elderly home 5 5 3 13
(2.0) (2.4) (4.2) (2.6)
Born in the Netherlands, n (%) b 209 178 64 451 0.204
(92.1) (86.8) (88.9) (89.5)
Education, n(%) b 0.011
Elementary/lower 93 99 21 213
(41.9) (49.5) (29.6) (43.2)
Secondary 111 81 37 229
(50.0) (40.5) (52.1) (46.5)
Higher/University 18 20 13 51
(8.1) (10.0) (18.3) (10.3)
MMSE, mean (0–30) (SD) a 19.6 18.7 20.4 19.3 0.150
(5.5) (6.4) (4.8) (5.8)
Time since symptoms in years, median (IQR) c 3.5 3.8 4.0 3.7 0.641
(2.0–5.0) (2.0–5.3) (2.7–5.5) (2.0–5.2)
Time since diagnosis in years, median (IQR) c 2.4 2.1 2.0 2.3 0.267
(1.4–3.7) (1.3–3.3) (1.3–3.0) (1.3–3.5)
Time in Case Management in years, median (IQR) d 2.1 1.7 NA 1.8 < 0.001
(1.3–3.1) (0.42–2.5) (1.1–2.8)
Multi-morbidity (more than two diseases),n (%) b 203 172 55 430 0.032
(88.7) (83.5) (76.4) (84.8)
Utility from the EQ-5D-Proxy (0–1) (SD) e 0.7 0.7 0.7 0.7 0.299
(0.2) (0.3) (0.2) (0.2)
EQ-5D utility from persons with dementia (0–1) (SD) 0.8 0.8 0.8 0.8 0.415
(0.2) (0.2) (0.2) (0.2)
QOL-AD proxy (13–52) (SD) 31.9 31.7 32.7 32.0 0.483
(5.1) (5.2) (5.0) (5.1)
Informal Caregiver Intensive Case Management Linkage model Control Total group P- value
Age (SD) a 64.5 64.4 65.8 64.6 0.687
(12.8) (12.4) (11.7) (12.5)
Female gender, n (%) b 163 136 49 348 0.390
(70.0) (63.6) (67.1) (66.8)
Spouse of the person with dementia, n (%) b 122 94 50 266 0.002
(53.3) (45.6) (69.4) (52.5)
Living together with person with dementia, n (%)b 127 100 50 277 0.007
(Continued)
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years, 95% CI: -5.0, -1.30), had more comorbid disorders (χ2 = 4 df = 1, p = 0.04), poorer Katz
scores (-2.1, 95% CI: -2.9, -1.2), and lower MMSE scores at baseline (3.2, 95% CI: 1.49, 5.0).
Clinical outcomes
Table 2 presents the results of the two-year clinical outcomes. Differences in the primary and
secondary outcomes between groups were small and not statistically significant.
Costs
Table 3 presents the adjusted mean costs and the adjusted differences in costs over 2 years
between the groups. We found that total costs were lowest for the ICMM followed by LM and
then the control group. However, there were no significant differences in total societal costs
between groups. Informal care costs in the ICMM and were significantly lower than in the con-
trol (95% CI -17,080;-1,674) and the LM group (95% CI -11,473;-1,660). Day center costs were
significantly lower in the ICMM group than the control group (95% CI -8,693;-50).
Economic evaluation
QALY of the person with dementia. The CE plane (Fig 2) shows that the majority of the
bootstrapped cost-effect pairs were located in the Southern quadrants (0.456 were in the South-
eastern and 0.541 was in the Southwestern) and very few pairs were in the northern quadrants
(0.001 was in the Northwestern and 0.002 in Northeastern quadrants, respectively) for the
comparison of ICMM versus control confirming the non-significant difference in QALYs [42].
This was confirmed in the CEA curve as the function goes to a probability of nearly 0.50 at
very high willingness-to-pay values (up to 10,000,000 €/QALY). The CEA curve showed that
the probability that ICMM was cost-effective in comparison with control was 0.992 at a WTP
Table 1. (Continued)
(55.5) (48.8) (70.4) (54.9)
Multi-morbidity (one or more diseases), n (%) b 149 119 50 318 0.129
(65.1) (57.8) (69.4) (62.7)
Mean number of conditions 3.8 3.8 3.0 3.7 0.330
(2.2) (2.2) (1.9) (2.1)
Education, n (%) b 0.370
Elementary/lower 36 31 10 77
(16.0) (15.3) (13.9) (15.4)
Secondary 139.0 127.0 38.0 304.0
(61.8) (62.6) (52.8) (60.8)
Higher/University 50 45 24 119
(22.2) (22.2) (33.3) (23.8)
EQ-5D utility (0–1) (SD) 0.8 0.9 0.9 0.8 0.261





eThe underlined scores indicates the more positive outcomes.
doi:10.1371/journal.pone.0160908.t001
Economic Evaluation of Case Management Models in Dementia Care
PLOS ONE | DOI:10.1371/journal.pone.0160908 September 21, 2016 9 / 20
value of 0 €/QALY and remained 0.992 at a WTP of 30,000 €/QALY (see Fig 3 for the CEAC of
all comparisons). Table 4 presents the results of the economic evaluation.
The ICER for LM versus control was 460,135 indicating that the loss of 1 QALY in the LM
is associated with cost savings of €460,135 in comparison with control. The majority of the
bootstrapped cost-effect pairs were in the Southern quadrants (0.369 in the Southeastern quad-
rant and 0.499 in the Southwestern quadrant) and few pairs were in the Northern quadrants
(0.055 in Northeastern quadrant and 0.077 in Northwestern quadrant). The CEAC showed
Table 2. Clinical outcomes rawmean scores and standard errors after 24 months.
ICMM LM Control
(n = 234) (n = 214) (n = 73)
primary outcomes Crudea Crudea Crudea ICMM vs control LM vs control ICMM vs LM






(95% CI) (95% CI) (95% CI)
Person with dementia QALY 1.25 0.04 1.18 0.04 1.27 0.06 -0.004 -0.01 0.01
(-0.14; 0.13) (-0.14; 0.12) (-0.09; 0.10)
Person with dementia utility scores
Baseline 0.74 0.01 0.7 0.02 0.74 0.03
6 months 0.68 0.02 0.65 0.02 0.7 0.04
12 months 0.64 0.02 0.58 0.03 0.68 0.04
18 months 0.58 0.03 0.54 0.03 0.57 0.05
24 months 0.52 0.03 0.5 0.03 0.5 0.05
Informal caregiver+ Person with dementia
QALY combined score
2.9 0.04 2.9 0.05 3.0 0.07 0.0004 -0.03 0.03
(-0.16; 0.16) (-0.19; 0.12) (-0.08; 0.15)
Informal caregiver utility scores
Baseline 0.83 0.01 0.85 0.01 0.86 0.02
6 months 0.82 0.01 0.84 0.01 0.83 0.02
12 months 0.82 0.01 0.82 0.02 0.84 0.02
18 months 0.82 0.01 0.81 0.02 0.84 0.02
24 months 0.83 0.01 0.82 0.02 0.83 0.03
NPI -1.54 0.33 -1.86
(-7.15; 4.07) (-5.37; 6.02) (-5.4; 1.67)
Baseline 16.8 1 19.9 1.1 15 1.6
6 months 21.7 1.6 22.1 1.7 22.7 2.7
12 months 19.7 1.4 21.5 1.5 19.8 2.2
18 months 22.4 1.6 25.2 1.8 25.1 3.2
24 months 23.2 1.7 26.7 2.1 26.7 3.4
GHQ-12 -0.11 -0.09 -0.02
(-0.95; 0.72) (-0.94; 0.76) (-0.59; 0.55)
Baseline 3.2 0.2 3.3 0.2 3 0.4
6 months 3.3 0.2 2.9 0.2 4.1 0.4
12 months 3.5 0.2 3.4 0.3 3.9 0.4
18 months 3.5 0.3 3.6 0.3 4.4 0.5
24 months 3.5 0.3 3.6 0.3 4 0.5
QALY is Quality-adjusted-life-year, ICER is Incremental Cost Effectiveness Ratio, NPI is Neuropsychiatric Inventory,GHQ-12 is General health
questionnaire-12,CI is Conﬁdence Interval
a Crude group means, no adjustment using inverse-propensity-score-weights
doi:10.1371/journal.pone.0160908.t002
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that the probability that the LMmodel was cost-effective in comparison to the control group
was 0.853 at a WTP value of 0 and this slightly decreased to 0.81 at a WTP value of 30,000
€/QALY, and to 0.5 at WTP of €3.24 million per QALY.
The ICER for the ICMM group versus the LM was -549,962 which indicated that there is a
saving of €-549,962 per additional QALY in the ICMM as compared to the LM. The compari-
son between ICMM and LM showed that the cost-effect pairs were again mostly in the South-
ern quadrants (0.556 in southeast quadrant and 0.421 in Southwest quadrant) and a minority
of pairs in the Northern quadrants (0.014 in Northeastern quadrant and 0.009 in the North-
western quadrant). The CEAC showed that for the QALY for the person with dementia the
probability that the ICMM was cost-effective in comparison to the LMmodel was 0.977 at a
WTP value of 0 €/QALY and 0.977 at a WTP of 30,000 €/QALY.
Table 3. Adjusted sub costs and costs along with differences between groups over 24 months (in Euros).
ICMM LM Control
n = 234 n = 214 n = 73
cost category Mean Mean Mean ICMM vs Controla LM vs Controla ICMM vs LMa
Costa Costa Costa
(SE) (SE) (SE) (95% CI) (95% CI) (95% CI)
General practice 1,279 1,362 1,088 -83 -274 192
-143 -225 -139 (-602;437) (-797;248) (-197;581)
Hospital and outpatient clinics 2,642 3,336 4,835 -2,193 -1,500 -693
-533 -770 -1,607 (-5,515;1,129) (-4,945; 1,946) (-2,534;1,147)
Overnight care 313 227 318 -5 -91 86
-162 -138 -321 (-708;697) (-768;586) (-332;504)
Day center 6,135 7,190 10,506 -4,371 -3,317 -1,055
-861 -893 -2,028 (-8,693;-50)* (-7,635;1,002) (-3,457;1,347)
Home care 18,109 22,468 16,555 1,554 5,912 -4,359
-3,460 -4,340 -5,264 (-10,731;13,838) (-7,360;19,185) (-15,293;6,576)
Home-making services 5,085 7,732 9,420 -4,335 -1,688 -2,647
-961 -1,384 -3,559 (-11,608;2,938) (-9,180;5,804) (-5,826;532)
Long term institutionalization 6,017 5,688 11,227 -5,210 -5,539 328
-1,091 -1,149 -3,281 (-11,972;1,551) (-12,318;1,240) (-2,793;3,450)
Welfare services 3,043 4,050 20,784 -17,742 -16,735 -1,007
-1,545 -2,674 -16,887 (-50,999;15,516) (-50,184;16,715) (-6,966;4,952)
Medications 2,220 1,867 1,766 454 100 354
-559 -425 -677 (-1,263;2,171) (-1,445;1,646) (-1,020;1,727)
Informal care costs 21,475 28,042 30,852 -9,377 -2,810 -6,567
-1,573 -1,958 -3,629 (-17,080;-1,674)** (-10,783;5,162) (-11,473;-1,660)***
Case management costs 3,120 2,469 N/A
-12 0
Total costs 69,435 84,155 107,627 -38,192 -23,472 -14,720
-5,980 -7,134 -23,411 (-85,606;9,222) (-71,386;24,442) (-33,014;3,575)
SE is standard error, CI is conﬁdence interval, ICMM is Intensive Case Management model, LM is Linkage model, CI is conﬁdence interval
*p = 0.047
** p = 0.017
***p = 0.009
a Inverse-propensity-score-weighted generalized linear model.
doi:10.1371/journal.pone.0160908.t003
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Fig 2. Cost-effectiveness plane.Cost-effectiveness plane for QALY of the person with dementia in the
ICMM vs. control group.
doi:10.1371/journal.pone.0160908.g002
Fig 3. Cost-effectiveness curves.Cost-effectiveness curves for all pairwise comparisons for QALY of the
person with dementia. The long dash represented the comparisons between LM versus control group. The
short dash compared the cost-effectiveness of the ICMM versus Control group. Dots were used to represent
the comparison of the ICMM compared to LM.
doi:10.1371/journal.pone.0160908.g003
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Combined QALY of the person with dementia and informal caregiver. The ICER for
the ICMM versus the control group was 9,495.671 indicating that the loss of one combined
(informal caregiver and person with dementia) QALY there would be a cost-saving of
€9,495,671. Based on the CE planes the majority of the bootstrapped cost-effect pairs were in
the Southern section (0.472 in Southwestern and 0.52 in Southeastern quadrant) for the com-
parison between ICMM compared to the control group (see S1 Fig for CEA plane). Fig 4 pres-
ents the CEAC curves per pairwise group comparison for the combined-QALY. At WTP
values of 0 and 30,000 €/QALY, the probability of cost-effectiveness for the ICMM versus con-
trol was 0.992 and this probability decreased with increasing WTP values. The ICER for the
LM versus the control group indicated €430,871 in cost savings per QALY lost. The compari-
son between LM and the control groups showed the majority of the cost-effect pairs (see S2 Fig
for CEA plane) in the Southwestern quadrant (0.559) and then smaller in amounts in the other
quadrants (0.296 in Southeastern, 0.096 in Northwestern and 0.049 in Northeastern
Table 4. Adjustedmean differences in outcomes and ICERs.
N Adjusted mean differences in costs (EUR) Effects CE Plane PCE at WTP = € 0 PCE at WTP = €30,000
ICMM vs. Control ICER
QALYa,b 521 -38,192 -0.004 9,581,433 0.992 0.992
(-85,606; 9,222) (-0.14; 0.13)
Combined 521 -38,192 0.0004 -91,127,631 0.992 0.992
QALYa,b (-85,606; 9,222) (-0.16; 0.16)
NPI c 521 -40,490 -1.54 26,345 1 0.89
(-89,014; 8,035) (-7.15; 4.07)
GHQ-12 c 521 -40,490 -0.11 361,012 1 1
(-89,014; 8,035) (-0.95; 0.72)
LM vs. control
QALYa,b 521 -23,472 -0.01 2,236,139 0.855 0.853
(-71,386; 24,442) (-0.14; 0.12)
Combined 521 -23,472 -0.03 686,587 0.84 0.855
QALYa,b (-71,386; 24,442) (-0.19; 0.12)
NPI c 521 -25,698 0.33 -78,356 1 0.63
(-74,654; 23,257) (-5.37; 6.02)
GHQ-12 c 521 -25,698 -0.09 288,562 1 0.98
(-74,654; 23,257) (-0.94; 0.76)
ICMM vs. LM
QALYa,b 521 -14,720 0.01 -2,260,818 0.977 0.977
(-33,014; 3,575) (-0.09; 0.10)
Combined QALYa,b 521 -14,720 0.03 -425,349 0.977 0.977
(-33,014; 3,575) (-0.08; 0.15)
NPI c 521 -14,791 -1.86 7,932 1 0.93
(-33,887; 4,305) (-5.4; 1.67)
GHQ-12 c 521 -14,791 -0.02 640,340 1 0.96
(-33,887; 4,305) (-0.59; 0.55)
ICMM is Intensive Case Management model, LM is Linkage model, CI is conﬁdence interval, QALY is Quality-adjusted-life-year, ICER is Incremental Cost
Effectiveness Ratio, NPI is Neuropsychiatric Inventory, GHQ-12 is General health questionnaire-12. PCE = probability that the intervention is cost-effective
as compared to its control condition.
a Inverse-propensity-score-weighted generalized linear models
b Including time after death
c Inverse-propensity-score-weighted generalized estimating equations
doi:10.1371/journal.pone.0160908.t004
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quadrants). At a WTP value of 0 €/QALY the probability of cost-effectiveness as 0.855 and this
decreased to 0.5 at a WTP of 7.5 million €/QALY.
The ICER for the ICMM versus the LM was –291,741 indicating that for one combined-
QALY gained, there are savings of €291,741 for the ICMM versus the LM. The majority of the
cost-effect pairs were in the Southern quadrants (0.556 in the Southeastern quadrants and
0.421 in the Southwestern quadrant). The CEAC showed that for combined-QALYs the proba-
bility of cost-effectiveness for ICMM versus LM was 0.977 at WTP values of 0 and 30,000
€/QALY and that this probability decreased with increasing ceiling ratios.
NPI. The ICER for NPI was 26,345 indicating that a 1 point improvement on the NPI in
the ICMM is associated with cost savings of €26,345 compared to the control group. For the
LM versus the control group, the ICER indicated that there were savings of €78,356 per one
point improvement in NPI score. For ICMM versus LM, the ICER indicates that there were
savings of €7,932 per one point improvement in NPI score. For all comparisons, the CEAC was
a decreasing function with increasing WTP values.
GHQ-12. The ICER for GHQ-12 was 361,012 indicating that a 1 point improvement on
the GHQ-12 in the ICMM group was associated with cost-savings of €361,012 as compared to
the control group. The ICER for the LM in comparison with control is 288,562 indicating that
1 point improvement on the GHQ-12 in the LM was associated with cost-savings of €288,562
as compared to the control group. For ICMM versus LM, the ICER was 640,340 indicating that
1 point decrease on the GHQ-12 in the ICMM was associated with cost-savings of €640,340 as
compared to the LM. For all comparisons, the CEAC decreased as the WTP value increases.
Fig 4. Cost acceptability curves for combined informal caregiver-person with dementia QALY for
Intensive case management, the linkage and control model.Cost-effectiveness curves for all pairwise
comparisons for the combined QALY of the person with dementia and informal caregiver. The long dash
represented the comparisons between LM versus control group. The short dash compared the cost-
effectiveness of the ICMM versus Control group. Dots were used to represent the comparison of the ICMM
compared to LM. The threshold value used was 30,000 euros per QALY.
doi:10.1371/journal.pone.0160908.g004
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Discussion
This study evaluated the cost-effectiveness of two case management models and no access to
case management (control). Informal care costs were significantly lower in the ICMM than the
control and LM group. Daycare costs were also significantly lower in the ICMM group than
the control group. For all outcomes, the probability that the ICMM was cost-effective in com-
parison with LM and the control group was larger than 0.97 at a threshold ratio of 0 €/incre-
mental unit of effect. Cost savings were accompanied by a small non-significant negative effect
on quality of life for the person with dementia in both case management groups compared to
the control group. Health policy makers will have to decide whether this small negative effect
on QALYs is acceptable based on the generated cost savings that the ICMMmodel appeared to
provide.
In the clinical paper, the ICMMmodel appeared to have a positive impact on caregiver’s
utility scores measured by the EQ-5D compared to the LMmodel but the differences could not
be considered clinically relevant [17]. However, this difference in quality of life did not trans-
late into a positive effect on QALYs in the economic evaluation. Total needs, met and unmet
care needs were significantly less in the ICMM compared with the control group [17].
A recent Cochrane review showed that case management participants used more social care
services and general practitioner consultations than control group participants but used similar
amounts of health care services [43]. This review found no differences in informal care time
between the case management group and usual care group [43]. In contrast, in our study we
found that informal care costs in ICMMwere significantly lower than in LM and control. How-
ever, like the Cochrane review, we did not find differences in long term care between groups at
two years follow-up [43].
This study has several strengths. Persons with dementia and their informal caregivers were
followed over a period of 2 years. This is a relatively long period of time and provides good
insight into resource utilization, quality of life, NPI scores of persons with dementia and mental
health of informal caregivers. Although 36 percent of persons with dementia died during this
study, we included them in our analysis and, thus, the high costs that are associated with care
just before death. Another strength is that the case management models were implemented for
many years previous to the start of this study. Therefore, the results have high external validity.
The economic evaluation was performed from a societal perspective and also included informal
care costs, thereby providing detailed insight into the economic consequences of dementia care
in the community.
Limitations
Study design. There are also some limitations that should be considered. The observa-
tional design of the study led to baseline differences as well as possible selection bias. By using
propensity scores, we tried to overcome this limitation in the analyses. There was potentially
more heterogeneity in the people recruited into this study compared to a randomized control
trial which may have resulted in greater uncertainty around outcomes.
Use of the EQ-5D. Another possible limitation is the use of the EQ-5D to measure quality
of life, as it may not be sensitive enough to pick up relevant changes. Furthermore, the EQ 5D
for the person with dementia was completed by a proxy (the informal caregiver). Approxi-
mately 263 persons with dementia also filled in EQ 5Ds themselves, but these were not used in
the economic evaluations because the data was not sufficiently complete and prone to bias.
Based on the paper of McPhail et al [24] we carefully rephrased the EQ-5D questions for the
proxy-report by the informal caregiver. We evaluated the dyadic effect of case management on
both the informal caregiver and the person with dementia by adding the two QALYs together
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Based on theory, QALYs can be aggregated across individuals (A QALY reflects a QALY
regardless of who loses it or gains it) [44]. However, there is a risk that this may lead to double
counting if the caregiver adjusts his/her health state valuation to incorporate some of the
impact on the person with dementia or the other way around. However, we are not aware of
any studies showing evidence of this effect.
Content of case management. Based on this study, we are not able to identify specific
components of case management that drive the cost-savings associated with case management
as compared to control. Although we did publish a process analysis on the barriers and imple-
mentation of case management [18] and interviewed case managers to understand the content
of their roles, we did not review care plans and evaluate multidisciplinary meetings content.
Measuring informal care. Our results show that the savings in informal care costs are the
main contributor to societal cost savings. It is possible that the case manager is effective in help-
ing informal caregivers to find alternatives to informal care for their loved one, although this was
not reflected by our cost estimates since daycare costs increased in the ICMM group compared to
the control group. However, the costs of home care were increased in the case management
groups as compared to control which may indicate a shift from informal care to home care.
Future research should evaluate what the case manager actually does and which components
of case management are effective. Moreover, since informal care time is notoriously hard to mea-
sure, future studies should find more reliable methods to measure informal care time accurately.
Cost measurement. Another potential limitation is that we used cost diaries to measure
costs. We tried to limit recall bias in the assessment of healthcare utilization rates by collecting
these data prospectively. We collected the cost diaries at each follow up visit during which the
diaries were checked for completeness.
Study power. Moreover, because cost-effectiveness was not the primary outcome of the
original study our results may be under-powered. However, it is for this reason that in eco-
nomic evaluations the focus is on estimation of intervention effects instead of on hypothesis
testing so that they can still provide useful information even when they are underpowered [45].
This study provides preliminary evidence that the intensive case management model is
cost-effective compared to a control group and the LMmodel as it appears to decrease total
costs. However, further research is still needed, since this was not a randomized controlled
trial. Therefore, all results should be interpreted with caution. Despite this methodological lim-
itation, results of the study are quite robust in showing that ICMM is cost-effective as com-
pared to LM and control.
Supporting Information
S1 Appendix. Background article Comparing Dutch case management care models for peo-
ple with dementia and their caregivers: The design of the COMPAS study.
(PDF)
S2 Appendix. Background article Community-Dwelling Persons with Dementia and Their
Informal Caregivers With andWithout Case Management: 2-Year Outcomes of a Prag-
matic Trial.
(PDF)
S1 Case Record Form. Caregiver interview file. Interview with informal caregiver (in Dutch).
(DOC)
S2 Case Record Form. Person with dementia interview file. Interview with the person with
dementia (in Dutch).
(DOC)
Economic Evaluation of Case Management Models in Dementia Care
PLOS ONE | DOI:10.1371/journal.pone.0160908 September 21, 2016 16 / 20
S3 Case Record Form. Caregiver questionnaire file. Questionnaire filled in by informal care-
giver (in Dutch).
(DOC)
S4 Case Record Form. Cost diary file. Cost diary filled in by the informal caregiver (in
Dutch).
(DOC)
S1 Dataset. Combined data set wide.
(DTA)
S2 Dataset. Bootstrapped file for pwd QALY reference control group.
(DTA)
S3 Dataset. Bootstrapped file for pwd QALY reference LM.
(DTA)
S4 Dataset. Bootstrapped file for combined QALY reference control group.
(DTA)
S5 Dataset. Bootstrapped file for combined QALY reference LM group.
(DTA)
S6 Dataset. CEAC curve for pwd QALY.
(DTA)
S7 Dataset. CEAC curve dataset for combined QALY.
(DTA)
S1 Fig. CEA plane for the combined QALY ICM vs control.
(TIF)
S2 Fig. CEA plane for the combined QALY LM vs control.
(TIF)
S1 Stata Syntax. The syntax do file.
(DO)
S1 Table. Table of cost prices. Unit costs used for economic evaluation. All prices were
adjusted for the year 2010 using consumer price index figures [26]. Healthcare utilization, and
absenteeism from paid and unpaid work was valued using Dutch standard costs [27]. Costs of
medications were valued using prices from the Royal Dutch Society for Pharmacy [28].
(DOCX)
S2 Table. Characteristics of different care models.
(DOCX)
Author Contributions
Conceptualization: JMV JB FM IE LvM KJ SR HvH.
Data curation: JMV KJ LvM.
Formal analysis: JMV JB IE.
Funding acquisition: FM SR HvH.
Investigation: JMV LvM.
Economic Evaluation of Case Management Models in Dementia Care
PLOS ONE | DOI:10.1371/journal.pone.0160908 September 21, 2016 17 / 20
Methodology: JMV JB SR IE KJ.
Project administration: JMV LvM SR HvH.
Resources: JB SR HvH.
Software: JMV JB IE.
Supervision: JB SR HvH.
Validation: JMV JB IE.
Visualization: JMV JB.
Writing – original draft: JMV JB.
Writing – review & editing: JMV JB FM IE LvM KJ SR HvH.
References
1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a
systematic review and metaanalysis. Alzheimers Dement. 2013; 9(1):63–75 e2. doi: 10.1016/j.jalz.
2012.11.007 PMID: 23305823
2. World Health Organization andWorld Health Organization and Alzheimer’s Disease International.
Dementia. A public health priority. Geneva: World Health Organization, 2012.
3. Alzheimer's Disease International. World Alzheimer Report 2010: The Global Economic Impact of
Dementia. 2010.
4. van der Roest HG, Meiland FJ, Haaker T, Reitsma E, Wils H, Jonker C, et al. Finding the service you
need: human centered design of a Digital Interactive Social Chart in DEMentia care (DEM-DISC). Stud
Health Technol Inform. 2008; 137:210–24. PMID: 18560083
5. Alzheimer Europe. Who cares? The state of dementia care in Europe. Luxembourg:: Alzheimer
Europe, 2006.
6. Peeters JM, Van Beek AP, Meerveld JH, Spreeuwenberg PM, Francke AL. Informal caregivers of per-
sons with dementia, their use of and needs for specific professional support: a survey of the National
Dementia Programme. BMCNurs. 2010; 9:9. doi: 10.1186/1472-6955-9-9 PMID: 20529271
7. Ministry of Health Welfare and Sport, Zorgverzekeraars Nederland, Alzheimer Nederland, ActiZ. Guide-
line for Integrated Dementia Care [excerpt]: An aid for the development of integrated dementia care.
2009.
8. Zwaanswijk M, Peeters JM, van Beek AP, Meerveld JH, Francke AL. Informal caregivers of people with
dementia: problems, needs and support in the initial stage and in subsequent stages of dementia: a
questionnaire survey. Open Nurs J. 2013; 7:6–13. doi: 10.2174/1874434601307010006 PMID:
23346266
9. Joling KJ, van Marwijk HW, van der Horst HE, Scheltens P, van de Ven PM, Appels BA, et al. Effective-
ness of family meetings for family caregivers on delaying time to nursing home placement of dementia
patients: a randomized trial. PLoS One. 2012; 7(8):e42145. doi: 10.1371/journal.pone.0042145 PMID:
22876304
10. Joling KJ, van Hout HP, Schellevis FG, van der Horst HE, Scheltens P, Knol DL, et al. Incidence of
depression and anxiety in the spouses of patients with dementia: a naturalistic cohort study of recorded
morbidity with a 6-year follow-up. Am J Geriatr Psychiatry. 2010; 18(2):146–53. doi: 10.1097/JGP.
0b013e3181bf9f0f PMID: 20104070
11. Case Management Society of America. What is a Case manager?: Case Management Society of
America; 2015 [February 24, 2015]. Available from: http://www.cmsa.org/Home/CMSA/
WhatisaCaseManager/tabid/224/Default.aspx.
12. Khanassov V, Vedel I, Pluye P. Case management for dementia in primary health care: a systematic
mixed studies review based on the diffusion of innovation model. Clin Interv Aging. 2014; 9:915–28.
doi: 10.2147/CIA.S64723 PMID: 24959072
13. Pinquart M, Sorensen S. Helping caregivers of persons with dementia: which interventions work and
how large are their effects? Int Psychogeriatr. 2006; 18(4):577–95. PMID: 16686964
14. Pimouguet C, Lavaud T, Dartigues JF, Helmer C. Dementia case management effectiveness on health
care costs and resource utilization: a systematic review of randomized controlled trials. J Nutr Health
Aging. 2010; 14(8):669–76. PMID: 20922344
Economic Evaluation of Case Management Models in Dementia Care
PLOS ONE | DOI:10.1371/journal.pone.0160908 September 21, 2016 18 / 20
15. Schoenmakers B, Buntinx F, Delepeleire J. Factors determining the impact of care-giving on caregivers
of elderly patients with dementia. A systematic literature review. Maturitas. 2010; 66(2):191–200. doi:
10.1016/j.maturitas.2010.02.009 PMID: 20307942
16. MacNeil Vroomen J, Van Mierlo LD, van de Ven PM, Bosmans JE, van den Dungen P, Meiland FJ,
et al. Comparing Dutch case management care models for people with dementia and their caregivers:
The design of the COMPAS study. BMC Health Serv Res. 2012; 12:132. doi: 10.1186/1472-6963-12-
132 PMID: 22640695
17. Vroomen JM, Bosmans JE, Ven PMvd, Joling KJ, Mierlo LDv, Meiland FJM, et al. Community-Dwelling
Patients With Dementia and Their Informal Caregivers With andWithout Case Management: 2-Year
Outcomes of a Pragmatic Trial. J AmMed Dir Assoc. 2015; 16(9):800.e1-8. doi: 10.1016/j.jamda.2015.
06.011 PMID: 26170035
18. Van Mierlo LD, Meiland FJ, Van Hout HP, Droes RM. Towards personalized integrated dementia care:
a qualitative study into the implementation of different models of case management. BMCGeriatr.
2014; 14:84. doi: 10.1186/1471-2318-14-84 PMID: 25005129
19. Banks P. Case management. In: Berman NPC, editor. Integrating services for older people–a resource
book for managers EHMA; 2004. p. 101–12.
20. Jansen AP, van Hout HP, van Marwijk HW, Nijpels G, de Bruijne MC, Bosmans JE, et al. (Cost)-effec-
tiveness of case-management by district nurses among primary informal caregivers of older adults with
dementia symptoms and the older adults who receive informal care: design of a randomized controlled
trial [ISCRTN83135728]. BMC Public Health. 2005; 5:133. PMID: 16343336
21. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neu-
rology. 1997; 48(5 Suppl 6):S10–6. PMID: 9153155
22. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979; 9
(1):139–45. PMID: 424481
23. Brooks R. EuroQol: the current state of play. Health policy. 1996; 37(1):53–72. PMID: 10158943
24. McPhail S, Beller E, Haines T. Two perspectives of proxy reporting of health-related quality of life using
the Euroqol-5D, an investigation of agreement. Med Care. 2008; 46(11):1140–8. doi: 10.1097/MLR.
0b013e31817d69a6 PMID: 18953224
25. Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ. [Measuring the quality of life
in economic evaluations: the Dutch EQ-5D tariff]. Ned Tijdschr Geneeskd. 2005; 149(28):1574–8.
PMID: 16038162
26. Centraal Bureau voor de Statistiek. prijsindexen 2010.
27. Hakkart-van Roijen L, Tann S, Boumans C. Handleiding voor kostenonderzoek: Methoden en stan-
daard kostprijzen voor economische evaluaties in de gezondheidzorg. Diemen: College voor Zorgver-
zekeringen; 2010.
28. index Z. G-standard. The Hague, The Netherlands: Z-Index BV, 2009.
29. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FFH. Handleiding voor kostenonder-
zoek: Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Rot-
terdam, the Netherlands: Instituut voor Medical Technology Assessment, Erasmus MC in opdracht van
College voor zorgverzekeringen, 2004.
30. McCaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF. A tutorial on propensity
score estimation for multiple treatments using generalized boosted models. Stat Med. 2013; 32
(19):3388–414. doi: 10.1002/sim.5753 PMID: 23508673
31. R Core Team. R: A language and environment for statistical computing R Foundation for Statistical
Computing. Vienna, Austria2014.
32. Stata Corp. Stata Statistical Software: Release 12. College Station, TX: Stata Corp LP; 2011.
33. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for
practice. Stat Med. 2011; 30(4):377–99. doi: 10.1002/sim.4067 PMID: 21225900
34. Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis
conducted within randomised controlled trials. Pharmacoeconomics. 2014; 32(12):1157–70. doi: 10.
1007/s40273-014-0193-3 PMID: 25069632
35. MacNeil Vroomen J, Eekhout I, Dijkgraaf MG, van Hout H, de Rooij SE, Heymans MW, et al. Multiple
imputation strategies for zero-inflated cost data in economic evaluations: which method works best?
Eur J Health Econ. 2015.
36. van Buuren S. Flexible imputation of missing data. Keiding N., Morgan B.J.T., Wikle C.K., van der Heij-
den P., editors. Boca Raton: CRC Press; 2012.
37. Rubin DB. Inference and Missing Data. Biometrika. 1976; 63(3):581–90.
Economic Evaluation of Case Management Models in Dementia Care
PLOS ONE | DOI:10.1371/journal.pone.0160908 September 21, 2016 19 / 20
38. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis:
the importance of controlling for baseline utility. Health Econ. 2005; 14(5):487–96. PMID: 15497198
39. Schafer JL. Analysis of Incomplete Multivariate Data. London: Chapman & Hall; 1997.
40. Nixon RM, Wonderling D, Grieve RD. Non-parametric methods for cost-effectiveness analysis: the cen-
tral limit theorem and the bootstrap compared. Health Econ. 2010; 19(3):316–33. doi: 10.1002/hec.
1477 PMID: 19378353
41. Willan AR, Briggs AH. Statistical Analysis of Cost-effectiveness Data. Senn S, editor: JohnWiley &
Sons Ltd; 2006.
42. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves—facts, fallacies and fre-
quently asked questions. Health Econ. 2004; 13(5):405–15. PMID: 15127421
43. Reilly S, Miranda-Castillo C, Malouf R, Hoe J, Toot S, Challis D, et al. Case management approaches
to home support for people with dementia. Cochrane Database Syst Rev. 2015; 1:CD008345. doi: 10.
1002/14651858.CD008345.pub2 PMID: 25560977
44. Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull.
2010; 96:5–21. doi: 10.1093/bmb/ldq033 PMID: 21037243
45. Briggs A. Economic evaluation and clinical trials: size matters. BMJ. 2000; 321(7273):1362–3. PMID:
11099268
Economic Evaluation of Case Management Models in Dementia Care
PLOS ONE | DOI:10.1371/journal.pone.0160908 September 21, 2016 20 / 20
